DOI : 10.1055/s-00034924

Nuklearmedizin - NuclearMedicine

Issue 02 · Volume 59 · April 2020 DOI: 10.1055/s-010-46300

Deutsche Gesellschaft für Nuklearmedizin e.V.
NuklearMedizin 2020
Leipzig, 06.-09.07.2020

58. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin

Kongresspräsident: Professor Dr. Markus Essler
Abstracts (HTML) Abstracts (PDF) List of Authors
V25
Meyer, PM; Grachev, ID; Becker, GA; Bronzel, M; Marsteller, D; Voges, O; Rabinovich, L; Zientek, F; Rullmann, M; Sattler, B; Patt, M; Strauss, E; Kluge, A; Savola, JM; Gordon, MF; Geva, M; Hesse, S; Barthel, H; Hayden, M; Sabri, O: High sigma-1 receptor (S1R) and very low dopamine 2/dopamine 3 receptor (D2/D3R) occupancy at clinically relevant doses of pridopidine in healthy volunteers (HV) and Huntington disease patients (HD): a F-18-Fluspidine and F-18-Fallypride PET study
V26
Aghakhanyan, G; Rullmann, M; Rumpf, J; Schroeter, ML; Patt, M; Classen, J; Sabri, O; Barthel, H: Does aggregated tau moderate functional and structural connectivities of the globus pallidus externus in progressive supranuclear palsy? Preliminary results of [18F]PI-2620 PET/MRI study
V27
Sauerbeck, J; Schmitt, J; Unterrainer, M; Harris, S; Palleis, C; Prix, C; Gehmeyr, M; Bötzel, K; Danek, A; Wlasich, E; Loosli, S; Beyer, L; Rauchmann, BS; Rominger, A; Bartenstein, P; Perneczky, R; Haass, C; Levin, J; Höglinger, G; Brendel, M: Dual-phase β-Amyloid PET for Assessment of Neuronal Injury and Amyloidosis in Corticobasal Syndrome
V28
Song, M; Barthel, H; van Eimeren, T; Marek, K; Beyer, L; Sauerbeck, J; Barbe, M; Schroeter, ML; Russell, DS; Stephens, A; Herms, J; Levin, J; Classen, J; Höglinger, G; Bartenstein, P; Villemagne, V; Drzezga, A; Seibyl, J; Sabri, O; Brendel, M: Binding characteristics of 18F-PI-2620 differentiate the clinically predicted tau isoform in suspected 3/4-repeat and 4-repeat tauopathies
V29
Fostitsch, JC; Boeker, M; Hellwig, S; Bormann, T; Meyer, PT; Frings, L: Prospektive Validierung der Überlebensprädiktoren [11C]PIB- und [18F]FDG-PET in einer klinischen Stichprobe mit kognitiver Störung
V30
Sauerbeck, J; Palleis, C; Brendel, M; Prix, C; Gehmeyr, M; Bötzel, K; Danek, A; Beyer, L; Song, M; Stephens, A; Barthel, H; Sabri, O; Drzezga, A; van Eimeren, T; Villemagne, V; Bartenstein, P; Perneczky, R; Haass, C; Levin, J; Höglinger, G: 18F-PI2620 Tau-PET for Assessment of Heterogeneous Neuropathology in Corticobasal Syndrome
V31
Hönig, MC; Willscheid, N; Bischof, GN; van Eimeren, T; Drzezga, A: Resistenz gegen Tau- und Amyloid-Pathologie unterstützt Super-Aging
V32
Alberts, I; Lu, J; Guan, Y; Cumming, P; Shi, K; Zuo, C; Rominger, A: [18F]-PM-PBB3-PET Tau Imaging in Alzheimer’s Dementia and PSP